News Releases
- June 2, 2020Annovis Bio Issued European Patent for Method of Treating Alzheimer’s Disease with ANVS401
- June 1, 2020Annovis Bio 2020 Annual Meeting of Stockholders to Be Held on June 3, 2020
- May 27, 2020Annovis Bio Files Patent Application for Method of Inhibiting, Preventing, or Treating Neurological Injuries Due to Viral and Other Infections Including COVID-19
- May 1, 2020Annovis Bio Interview to Air on Bloomberg International on the RedChip Money Report
- April 30, 2020Annovis Bio Announces Plans for a New Phase II Clinical Trial to Treat 68 Parkinson’s and Alzheimer’s Patients
- April 23, 2020Annovis Bio Publishes Results of Alzheimer’s and Parkinson’s Animal Studies
- April 13, 2020Annovis Bio to Hold Investor Webinar and Q&A Session with CEO on April 14
- February 27, 2020Annovis Awarded $1.7 Million NIH Grant for ANVS401 Chronic Toxicology Studies
- February 20, 2020Annovis Issued Patent for Method of Treating Parkinson’s Disease and Other Lewy Body Diseases
- February 13, 2020Annovis Bio Announces Update on Phase II Clinical Trial for Alzheimer’s Disease
- ,
Media Coverage
Events & Presentations
-
Annovis R&D Day Webcast View Webcast
-
Annovis Corporate Presentation - February 2024
-
AD-PD Conference - March 2022
Filings
Filings
Description
Date Filed
Available Formats
E-mail Alerts
Back to Top